MSD Oncology is extending an open invitation to the Australian research community to participate in the MSD Oncology Grant Program. The grant aims to establish a global community of health policy researchers driving evidence-based and forward-looking health policy recommendations that will improve health outcomes for cancer patients. This competitive grant will be issued publicly and […]

The intent of this Request for Proposal (RFP) is to support research to increase knowledge of COVID-19 epidemiology, infection, pathophysiology, and potential prevention measures. We are particularly interested in supporting research in the following areas: Understanding impact of COVID on communities, spectrum of disease in communities, and level of herd immunity Postmortem Analysis of deceased […]

Projects that will be considered for Pfizer support will focus on increasing awareness of the role of nuclear scintigraphy (inclusive of Tc99m PYP, Tc-99m DPD and Tc-99m HDMP) in the diagnostic work up of patients with suspected cardiac amyloidosis along with other multimodality imaging techniques: Image acquisition and processing Image interpretation and reporting Common imaging […]

Projects that will be considered for Pfizer support will focus on long-acting growth hormone (LAGH) research, specifically: Morbidities in growth disorders Novel strategies including Quality of Life and Patient Reported Outcomes to evaluate and treat growth disorders Comparison of clinical effects of daily vs long-acting growth hormone Comparative pathophysiology of daily vs long-acting growth hormone […]

The submitted proposals should aim to inform the scientific and clinical community and to advance the discussion around non-invasive biomarkers and diagnostic tools for NASH (Nonalcoholic steatohepatitis). Funding & duration Up to US $250,000 (approx. AUD $387,000). Submission requirements & due date Applications must be submitted for internal review by 23 July 2020. Please email rbinternational@adelaide.edu.au if you are […]

There remains unmet need in the management of osteoarthritis and chronic pain associated with osteoarthritis. Given the recent and anticipated cancellation of many medical conferences worldwide, healthcare providers will have difficulty staying current with the newest recommendations for management/guidelines of OA and the emerging data for research/therapies under development to treat OA and OA pain. […]

In response to the global COVID-19 pandemic, the Johns Hopkins Center for Alternatives to Animal Testing (CAAT) at the Bloomberg School of Public Health is redirecting part of our grant program to help accelerate the discovery of mechanisms, medicines, and vaccines for COVID-19. Our goal is to centralize information and stimulate funding of the development […]

This AXA Research Fund is opening a call for projects in the following areas: Protecting vulnerable populations from epidemics and catastrophes, including COVID-19: be it migrants, informal settlements, workers in the informal economy, isolated people, people with disabilities, the elderly. Improving data collection and quality in health: how can data and technology help us get […]